Trial intelligence / Profile preview

Dexmedetomidine Influence on Spinal Anesthesia with Chloroprocaine in Knee Arthroscopy

NCT02282319Phase 4Completed

Start
Oct 2014
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine in knee arthroscopy (3 arms). Primary endpoints: Sensory block regression L2 dermatome up to 360 minutes and Motor block regression up to 240 minutes. Started Oct 2014; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

knee arthroscopy

Beyond the preview

Go deeper on NCT02282319.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02282319.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call